Atticus Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1
Closed -$10 487
2025
Q2
$10 Buy
+1
New +$10 ﹤0.01% 677
2023
Q2
Sell
-16
Closed -$377 609
2023
Q1
$377 Buy
+16
New +$430 ﹤0.01% 516
2022
Q4
Sell
-1
Closed 607
2022
Q3
$0 Hold
1
﹤0.01% 609
2022
Q2
$0 Buy
+1
New +$35 ﹤0.01% 632
2021
Q3
Sell
-223
Closed -$7K 439
2021
Q2
$7K Buy
+223
New +$7.34K ﹤0.01% 326

Other funds holding OGN

Atticus Wealth Management's OGN Position: Q3 2025 in Review

Atticus Wealth Management sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 1 share — an estimated $10 sold.

Atticus Wealth Management first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $7K in Q2 2021. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Atticus Wealth Management reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • Atticus Wealth Management sold 1 Organon & Co share in Q3 2025, an estimated $10.
  • Atticus Wealth Management first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Atticus Wealth Management's Organon & Co position peaked at $7K in Q2 2021.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.